Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S ...

The drug’s global sales were estimated to be about $28 billion last year, according to FactSet. Novo Nordisk said Friday it is opposed to the Medicare negotiation program because it could hurt ...

UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding ... to the data firm FactSet. UnitedHealth operates ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a ... according to the data firm FactSet.

NORWALK, Conn., Jan. 15, 2025 (GLOBE NEWSWIRE) -- FactSet, a global financial digital platform and enterprise solutions provider, today announced the launch of Pitch Creator, a groundbreaking ...

Medicare usually requires that people are 65 years old or above to qualify for a plan. However, some individuals can qualify for Medicare earlier if they have a disability or certain medical ...

Q1 GAAP revenues of $568.7 million, up 4.9% from Q1 2024.Organic Q1 ASV of $2,258.8 million, up 4.5% year over year.Q1 GAAP operating margin of 33.6%, down approximately 120 bps year over year ...

The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...

As we near the turnover of administrations, Health Affairs Forefront offers a series of articles from leaders at the Centers for Medicare and Medicaid Services offering their thoughts on the major ...